ArticlePharmacological reports : PR2013

Levosimendan and its metabolite OR-1896 elicit KATP channel-dependent dilation in resistance arteries in vivo.

Ildikó Gödény et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.